文献速递前列腺癌

da Vinci单孔机器人辅助根治性前列腺切除术的初步经验

Initial Experience with da Vinci Single-port Robot-assisted Radical Prostatectomies.
PubMed 文献 · Eur Urol · 2019-04-19

该研究回顾性分析了三位高容量机器人前列腺手术医生使用da Vinci单孔(SP)机器人系统实施单孔机器人辅助根治性前列腺切除术(spRARP)的初步经验,共49例患者。中位手术时间161分钟,中位出血量200ml,并发症率8.1%。结论认为该手术安全可行,但需进一步研究以确定其非劣效性及对患者美观和疼痛的影响。

要点

  • 49例spRARP患者中,中位手术时间161分钟,中位出血量200ml。
  • 4例发生Clavien 2级并发症,并发症率8.1%。
  • 三位医生均在第三例时手术时间降至200分钟以内。

核心结论

  • da Vinci SP系统spRARP安全可行,手术时间和出血量可接受。
  • 需进一步研究确立对da Vinci Xi和Si系统的非劣效性,以及spRARP对患者自评美观和疼痛的影响。

研究设计与样本

  • 回顾性综述,纳入三位高容量机器人前列腺手术医生利用da Vinci SP机器人系统实施的spRARP初始经验,共49例患者。
  • 手术采用传统耻骨后或保留Retzius入路。

主要发现

  • 队列中位年龄62岁,中位前列腺特异性抗原6.4。
  • 35例(71%)就诊时为cT1c病变,92%为Gleason分级分组≥2,最终病理85%为pT2。
  • 中位手术时间161分钟,中位出血量200ml,实施了7例保留Retzius病例。
  • 发生4例Clavien 2级并发症(并发症率8.1%),中位住院时间1天,中位导尿管留置时间7天。
  • 三位医生均在第三例时手术时间<200分钟。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Single-port robotic surgery is being adopted for various surgical procedures. There have been interest in and clinical use of single-port robot-assisted radical prostatectomy (spRARP), but little reported data on feasibility and early outcomes. OBJECTIVE: To describe our institution's initial experience with spRARP utilizing the da Vinci single-port (SP) robotic system. DESIGN, SETTING, AND PARTICIPANTS: A retrospective review of the initial experience of three high-volume robotic prostate surgeons performing an spRARP utilizing the da Vinci SP robotic system was carried out. SURGICAL PROCEDURE: An spRARP using the da Vinci SP robotic system was performed following the traditional retropubic or Retzius-sparing approach. MEASUREMENTS: Patient demographics, operative time, blood loss, postoperative hospital stay, complications, and catheter duration were obtained and analyzed. RESULTS AND LIMITATIONS: In a cohort of 49 patients undergoing spRARP, median age was 62yr and prostate-specific antigen 6.4. Of the patients, 35 (71%) had cT1c disease on presentation, 92% had Gleason grade group ≥2 disease, and 85% were pT2 on final pathology. Median operative time was 161min. Median blood loss was 200ml. Seven Retzius-sparing cases were performed. Four Clavien 2 complications occurred (complication rate 8.1%). Median hospital stay was 1d and median catheter duration 7d. Operative time was <200min for all three surgeons by their third case. CONCLUSIONS: The da Vinci SP system spRARP is safe and feasible, with acceptable operative time and blood loss. Further research is needed to establish noninferiority to the da Vinci Xi and Si systems, and impact of spRARP on patient-assessed cosmesis and pain. PATIENT SUMMARY: Robotic prostatectomy using a purpose-built da Vinci single-port robotic system is safe and feasible, and warrants further study to determine whether it can improve patient outcomes.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Agarwal DK, Sharma V, Toussi A, et al. Initial Experience with da Vinci Single-port Robot-assisted Radical Prostatectomies. Eur Urol. 2019. PMID: 31010600. doi:10.1016/j.eururo.2019.04.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。